Concepedia

Publication | Open Access

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial

DOIFull Paper Access

109

Citations

23

References

2023

Year

Wenwen Zhang, Shuang Tong, Bingyang Hu, Tao Wan, Haowen Tang, Feilong Zhao, Tianyu Jiao, Junfeng Li, Ze Zhang, Jinping Cai,
Journal for ImmunoTherapy of Cancer

Abstract

Chinese Clinical Trial Registry, ChiCTR1900023914.

References

YearCitations

Page 1